AnalystsAndy ChenAndy Chen's Stock Forecasts
AnalystsAndy Chen
Sectors:
Industries:
Analyst Ranking
Top 15%
#779 out of 5254 analysts
Average Return
+35.54%
Win Rate
62%16 out of 26
Risk vs Reward
Poor
Good
Andy Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-18 - 2024-05-17 | Strong Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-15 - 2025-02-14 | Buy |
Zenas Biopharma IncZBIO | +157.44% | $7.66 | $19.72 | 2025-02-04 - 2026-02-03 | Buy |
Oruka Therapeutics IncORKA | +143.14% | $14.21 | $34.55 | 2025-02-04 - 2026-02-03 | Buy |
Bridgebio Pharma IncBBIO | +91.54% | $40.07 | $76.75 | 2025-06-17 - 2026-04-17 | Buy |
Andy Chen Analyst Color
Get additional color on Andy Chen's coverage of popular stocks
Andy Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Palisade Bio IncPALI | 1 | Buy | $7.00 | +191.67% | Initiates Coverage On | 11 days ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $48.00 | +232.64% | Initiates Coverage On | 11 days ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $98.00 | +5.08% | Initiates Coverage On | 11 days ago |
Pharvaris NvPHVS | 1 | Buy | $42.00 | +46.96% | Initiates Coverage On | 11 days ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $24.00 | +30.86% | Upgrades | a month ago |
Vera Therapeutics IncVERA | 2 | Buy | $88.00 | +108.04% | Upgrades | a month ago |
Immunovant IncIMVT | 2 | Buy | $50.00 | +70.65% | Upgrades | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $548.00 | +24.21% | Upgrades | 3 months ago |
Verona Pharma PLCVRNA | 1 | Buy | $170.00 | +59.01% | Initiates Coverage On | 10 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $49.00 | -36.16% | Initiates Coverage On | 10 months ago |
Avidity Biosciences IncRNAM | 1 | Buy | $55.00 | +272.88% | Initiates Coverage On | 10 months ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $21.00 | +40.47% | Upgrades | a year ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Argenx SeARGX | 1 | Buy | $697.00 | N/A | Upgrades | a year ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | N/A | Reiterates | 2 years ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | N/A | Upgrades | 2 years ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $312.00 | N/A | Initiates Coverage On | 2 years ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $60.00 | N/A | Assumes | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.